We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Genzyme Therapeutics

4620 Kingsgate, Cascade Way, Oxford Business Park South, Oxford, Oxfordshire, OX4 2SU
Telephone: +44 (0)1865 405 200
Fax: +44 (0)1865 774 172
WWW: http://www.genzyme.co.uk
Medical Information Direct Line: +44 (0)1865 405 283
Medical Information e-mail: ukmedinfo@genzyme.com
Customer Care direct line: +44 (0)1865 405 200
Medical Information Facsimile: +44 (0)1865 774 172
Patient Information Leaflet last updated on medicines.ie: 15/09/2017
PIL Myozyme 50 mg, powder for concentrate for solution for infusion.

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 15/09/2017 and displayed until Current
Reasons for adding or updating:
  • Change to section 6 - date of revision
  • Change to other sources of information section
Updated on 29/08/2017 and displayed until 15/09/2017
Reasons for adding or updating:
  • Improved presentation of PIL
Updated on 23/08/2017 and displayed until 29/08/2017
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 17/07/2017 and displayed until 23/08/2017
Reasons for adding or updating:
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
Updated on 17/02/2015 and displayed until 17/07/2017
Reasons for adding or updating:
  • Addition of information on reporting a side effect.
Updated on 23/09/2014 and displayed until 17/02/2015
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
  • Changes to therapeutic indications
Updated on 30/08/2012 and displayed until 23/09/2014
Reasons for adding or updating:
  • Removal/change of distributor
Updated on 15/12/2011 and displayed until 30/08/2012
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 25/02/2011 and displayed until 15/12/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to side-effects
  • Change to further information section
  • Change to date of revision
Updated on 15/09/2010 and displayed until 25/02/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 23/06/2010 and displayed until 15/09/2010
Reasons for adding or updating:
  • New PIL for medicines.ie

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Alglucosidase alfa